368 related articles for article (PubMed ID: 7528768)
1. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant.
Isobe H; Moran T; Li S; Young A; Nathenson S; Palese P; Bona C
J Exp Med; 1995 Jan; 181(1):203-13. PubMed ID: 7528768
[TBL] [Abstract][Full Text] [Related]
2. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
[TBL] [Abstract][Full Text] [Related]
3. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.
Anderson RW; Bennink JR; Yewdell JW; Maloy WL; Coligan JE
Mol Immunol; 1992 Sep; 29(9):1089-96. PubMed ID: 1495499
[TBL] [Abstract][Full Text] [Related]
4. Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
Oukka M; Manuguerra JC; Livaditis N; Tourdot S; Riche N; Vergnon I; Cordopatis P; Kosmatopoulos K
J Immunol; 1996 Oct; 157(7):3039-45. PubMed ID: 8816413
[TBL] [Abstract][Full Text] [Related]
5. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
Carreno BM; Turner RV; Biddison WE; Coligan JE
J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
[TBL] [Abstract][Full Text] [Related]
6. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
[TBL] [Abstract][Full Text] [Related]
7. No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.
Freer G; Senesi S
Immunol Lett; 1993 Jun; 36(3):305-12. PubMed ID: 8370602
[TBL] [Abstract][Full Text] [Related]
8. Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes.
Vitiello A; Heath WR; Sherman LA
J Immunol; 1989 Sep; 143(5):1512-7. PubMed ID: 2474602
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
10. Viral hemagglutinin augments peptide-specific cytotoxic T cell responses.
Ertel C; Millar NS; Emmerson PT; Schirrmacher V; von Hoegen P
Eur J Immunol; 1993 Oct; 23(10):2592-6. PubMed ID: 8405059
[TBL] [Abstract][Full Text] [Related]
11. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
12. A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
Oukka M; Riché N; Kosmatopoulos K
J Immunol; 1994 May; 152(10):4843-51. PubMed ID: 8176207
[TBL] [Abstract][Full Text] [Related]
13. CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein.
Gschoesser C; Almanzar G; Hainz U; Ortin J; Schonitzer D; Schild H; Saurwein-Teissl M; Grubeck-Loebenstein B
Vaccine; 2002 Nov; 20(31-32):3731-8. PubMed ID: 12399202
[TBL] [Abstract][Full Text] [Related]
14. Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination.
Tourdot S; Oukka M; Manuguerra JC; Magafa V; Vergnon I; Riché N; Bruley-Rosset M; Cordopatis P; Kosmatopoulos K
J Immunol; 1997 Sep; 159(5):2391-8. PubMed ID: 9278330
[TBL] [Abstract][Full Text] [Related]
15. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
[TBL] [Abstract][Full Text] [Related]
16. Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin.
Gould KG; Scotney H; Brownlee GG
J Virol; 1991 Oct; 65(10):5401-9. PubMed ID: 1716691
[TBL] [Abstract][Full Text] [Related]
17. Recognition of disparate HA and NS1 peptides by an H-2Kd-restricted, influenza specific CTL clone.
Kuwano K; Reyes VE; Humphreys RE; Ennis FA
Mol Immunol; 1991; 28(1-2):1-7. PubMed ID: 1707132
[TBL] [Abstract][Full Text] [Related]
18. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
Falk K; Rötzschke O; Deres K; Metzger J; Jung G; Rammensee HG
J Exp Med; 1991 Aug; 174(2):425-34. PubMed ID: 1713253
[TBL] [Abstract][Full Text] [Related]
19. Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope.
Deckhut AM; Allan W; McMickle A; Eichelberger M; Blackman MA; Doherty PC; Woodland DL
J Immunol; 1993 Sep; 151(5):2658-66. PubMed ID: 7689611
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
Blake NW; Kettle S; Law KM; Gould K; Bastin J; Townsend AR; Smith GL
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2393-8. PubMed ID: 7561783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
